SCHEMBL6990048

SCHEMBL6990048

CCOC(=O)N1CCC(=C2c3cc(C)ccc3CCn3ccnc32)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 10/20 0.52
SLC6A15 Q9H2J7 7/20 0.47
LMNA P02545 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
MEN1 O00255 1/20 0.47
NPC1 O15118 1/20 0.47
CACNA1F O60840 1/20 0.47
NR1I2 O75469 1/20 0.47
GMNN O75496 1/20 0.47
USP2 O75604 1/20 0.47
ABCB11 O95342 1/20 0.47
TP53 P04637 1/20 0.47
CHRM2 P08172 1/20 0.47
ABCB1 P08183 1/20 0.47
CYP3A4 P08684 1/20 0.47
ADORA3 P0DMS8 1/20 0.47
CYP2C8 P10632 1/20 0.47
CYP2D6 P10635 1/20 0.47
MAPT P10636 1/20 0.47
CYP2C9 P11712 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18102086 0.88 HRH1 (0.67) HRH1SLC6A15LMNASMN1; SMN2MEN1
SCHEMBL6990866 0.84 SLC6A15 (0.67) HRH1SLC6A15LMNASMN1; SMN2MEN1
SCHEMBL7138894 0.80 HRH1 (0.48) HRH1SLC6A15LMNASMN1; SMN2MEN1
SCHEMBL6990175 0.80 HRH1 (0.48) HRH1SLC6A15LMNASMN1; SMN2MEN1
SCHEMBL9167967 0.74 PTAFR (0.64) HRH1SLC6A15FNTAFNTBPTAFR
SCHEMBL7142948 0.74 HRH1 (0.55) HRH1SLC6A15LMNASMN1; SMN2MEN1
SCHEMBL7893725 0.74 HRH1 (0.65) HRH1SLC6A15LMNASMN1; SMN2MEN1
SCHEMBL6985481 0.73 HRH1 (0.49) HRH1ABCB11TP53CHRM2ADORA3
SCHEMBL5265654 0.71 SLC6A15 (0.82) HRH1SLC6A15LMNASMN1; SMN2MEN1
SCHEMBL5060492 0.71 HRH1 (0.47) HRH1ABCB11TP53CHRM2ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0588858-B1 IMIDAZO 2,1-b] 3]BENZAZEPINE DERIVATIVES, COMPOSITIONS AND METHOD OF USE JANSSEN PHARMACEUTICA NV (BE) 2003-09-17 EP disclosed
US-5468743-A Imidazo[2,1-b]benzazepine derivatives, compositions and method of use JANSSEN PHARMACEUTICA N.V. (BE) 1995-11-21 US disclosed
EP-0588858-A1 IMIDAZO 2,1-b] 3]BENZAZEPINE DERIVATIVES, COMPOSITIONS AND METHOD OF USE JANSSEN PHARMACEUTICA N.V. (BE) 1994-03-30 EP disclosed
WO-1992022551-A1 IMIDAZO[2,1-b][3]BENZAZEPINE DERIVATIVES, COMPOSITIONS AND METHOD OF USE JANSSEN PHARMACEUTICA N.V. (BE) 1992-12-23 WO disclosed
EP-0518435-A1 Imidazo[2,1-b][3]benzazepine derivatives, compositions and method of use JANSSEN PHARMACEUTICA N.V. (BE) 1992-12-16 EP disclosed